Research On Evaluation Of Financial Competitiveness Of Hisun Pharmaceutical

With the continuous economic development,aging and policy-driven factors,China’s pharmaceutical industry has moved into a phase of rapid development.But China is gradually emphasizing the governance of the pharmaceutical industry,actively promoting supply-side reform,eliminating backward production capacity,and increasing the market regulation of pharmaceutical enterprises,while foreign pharmaceutical giants are focusing on China’s pharmaceutical market,bringing certain challenges to the development of China’s pharmaceutical enterprises.In a highly competitive environment,enterprises need to improve their core competitiveness if they want to sustain stable development,and financial competitiveness,as an important part of core competitiveness,is vital to be evaluated scientifically and rationally,which is related to the future development of enterprises.This paper firstly collates the results of domestic and foreign scholars’ research on financial competitiveness,organizes the specific connotation of financial competitiveness,and theoretical bases used for financial competitiveness evaluation are introduced;Secondly,this paper selects Hisun Pharmaceuticals as the research object and briefly introduces it,mainly including the operation and research and development;again,based on the characteristics of the pharmaceutical industry,we construct a financial competitiveness evaluation index system consisting of six indicators: solvency,profitability,operating capacity,growth capacity,profitability and research and development capacity,and evaluate the financial competitiveness of Hisun Pharmaceuticals with the help of factor analysis and entropy method.Finally,through the analysis of the evaluation results,the problems affecting the financial competitiveness of Hisun Pharmaceuticals were identified as follows: inadequate cost control,low turnover of accounts receivable,weak solvency,and low utilization of capital,etc.Based on the analysis,Hisun Pharmaceuticals proposed to reduce costs,increase operating income,optimize accounts receivable management and capital structure,and improve the competitiveness of the company.Based on the analysis,Hisun Pharmaceuticals made recommendations to reduce costs,improve operating income,optimize accounts receivable management and capital structure,and enhance capital utilization efficiency.